Get the Stockscreener App
0.00
100.00%
-1.19
After Hours:
1.00
1.00
+
Orgenesis Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$1.19
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
$662.00K
Net Income/Loss:
$-29.02M
P/E Ratio:
0.00
EPS:
-8.5
Net Cash Flow:
$-12.54M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-76.19%
1Y Performance:
-86.10%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$1.19
Orgenesis Inc Stock (ORGS) Company Profile
Compare ORGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGS
Orgenesis Inc
|
0.00 | 0 | 662.00K | -29.02M | -12.54M | -8.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Orgenesis Inc Stock (ORGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-18 | Initiated | Dawson James | Buy |
Orgenesis Inc Stock (ORGS) Latest News
In-Depth 2025 Common Warts Industry Forecast: Plan Your Strategy for 2034 Success - WhaTech
Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts Market: Pushing the Bounda... - WhaTech
Will Orgenesis Inc. (45O) stock benefit from infrastructure billJuly 2025 Patterns & Daily Technical Stock Forecast Reports - newser.com
Can Orgenesis Inc. (45O) stock withstand sector downturnsJuly 2025 Summary & Free Long-Term Investment Growth Plans - newser.com
Orgenesis Presents Technology Update To FDA/CBER Experts - AOL.com
Why Orgenesis Inc. (45O) stock remains top ratedWeekly Market Report & Growth Focused Stock Pick Reports - newser.com
Is Orgenesis Inc 45O a good long term investmentFibonacci Retracement Levels & Explosive Trading Portfolio - earlytimes.in
Is Orgenesis Inc. (45O) stock a top pick for value investorsTrade Exit Report & Low Drawdown Trading Strategies - newser.com
Why Institutions Believe Beeyu Overseas Limited Is Undervalued TodayStock Buyback Updates & High Profit Market Tips - earlytimes.in
Orgenesis (NASDAQ:ORGS) and Oragenics (NYSE:OGEN) Critical Contrast - Defense World
Orgenesis Faces Multiple Leadership Resignations in August - MSN
Orgenesis subsidiary Theracell enters $1 million convertible loan agreement By Investing.com - Investing.com South Africa
Orgenesis subsidiary Theracell enters $1 million convertible loan agreement - Investing.com India
Orgenesis Subsidiary Secures Convertible Loan Agreement - TipRanks
Riku Dining Group Ltd sees U.S. IPO of 2.3 million Class A ordinary shares - MarketScreener
LB Pharmaceuticals raises $285 million in US IPO - MarketScreener
Genital Warts Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential - Barchart.com
Exclusive-Stablecoin issuer Figure Technologies set to upsize IPO as demand for crypto-related stocks soars, source says - MarketScreener
Orgenesis’s Sharp Swings Define Its High-Risk Biotech Story - Finimize
Orgenesis Inc Stock (ORGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.50%
Cap:
|
Volume (24h):